Daniel, Maria http://orcid.org/0000-0002-6525-0882
Szymanik-Grzelak, Hanna http://orcid.org/0000-0001-7233-5481
Turczyn, Agnieszka http://orcid.org/0000-0001-7117-6597
Pańczyk-Tomaszewska, Małgorzata http://orcid.org/0000-0002-4566-7074
Clinical trials referenced in this document:
Documents that mention this clinical trial
Lactobacillus rhamnosus PL1 and Lactobacillus plantarum PM1 versus placebo as a prophylaxis for recurrence urinary tract infections in children: a study protocol for a randomised controlled trial
https://doi.org/10.1186/s12894-020-00723-1
Article History
Received: 22 February 2020
Accepted: 17 September 2020
First Online: 23 October 2020
Ethics approval and consent to participate
: The Bioethics Committee of Medical University of Warsaw approved the study protocol, the comittee’ reference number is KB/6/2018.
: Not applicable.
: The Miralex company had no input into the design of the trial. The authors have no competing financial or no-financial interests.